Related references
Note: Only part of the references are listed.A Case Report of Successful Treatment of Crohn's Disease and Psoriasis With Guselkumab
Laurie B. Grossberg
INFLAMMATORY BOWEL DISEASES (2019)
Pharmacological development in hidradenitis suppurativa
Lukasz Matusiak et al.
CURRENT OPINION IN PHARMACOLOGY (2019)
Guselkumab in the treatment of hidradenitis suppurativa: A retrospective chart review
Rachel G. Casseres et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Guselkumab in the treatment of severe hidradenitis suppurativa
M. Kovacs et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
Guselkumab for the treatment of psoriasis
Matteo Megna et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2018)
Association of Psoriasis With Inflammatory Bowel Disease A Systematic Review and Meta-analysis
Yun Fu et al.
JAMA DERMATOLOGY (2018)
Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study
Inge E. Deckers et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
The Clinical Significance of Increased Serum Proinflammatory Cytokines, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Patients with Hidradenitis Suppurativa
D. Jimenez-Gallo et al.
MEDIATORS OF INFLAMMATION (2017)
Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases
Coline Faivre et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Systemic associations of hidradenitis suppurativa
John J. Kohorst et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Hidradenitis suppurativa: the role of immune dysregulation
Genevieve Kelly et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2014)
Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa A Parallel Randomized Trial
Alexa B. Kimball et al.
ANNALS OF INTERNAL MEDICINE (2012)
Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa
Christoph Schlapbach et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Th17 and Regulatory T Cells in Mediating and Restraining Inflammation
Dan R. Littman et al.
CELL (2010)
The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
Antonella Di Cesare et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Share Paper
